RAPT THERAPEUTICS INC (RAPT)
US75382E1091 - Common Stock
ChartMill assigns a Buy % Consensus number of 53% to RAPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.72. This target is 56.32% above the current price.
RAPT was analyzed by 15 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about RAPT.
In the last month the buy percentage fell by 20 points. So the trust of analysts is decreasing.
RAPT was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-11-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-11-11 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-09-09 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-07-23 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-05-10 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-05-10 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-22 | UBS | Downgrade | Buy -> Neutral |
| 2024-02-21 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-02-21 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-21 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-02-21 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-02-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-02-16 | Evercore ISI Group | Initiate | Outperform |
| 2024-02-15 | Wolfe Research | Initiate | Outperform |
| 2023-11-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-14 | Berenberg | Initiate | Buy |
| 2023-08-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | Stifel | Initiate | Buy |
| 2023-06-15 | Barclays | Initiate | Overweight |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |